Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers
Cancers · 14.09.2024 · 16 (18) · 3158
DOI: 10.3390/cancers16183158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 14.09.2024. Verfasst von Ruchi Shah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, …. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, V Foundation, 2018 Prostate Cancer Foundation Challenge Award.
Abstract (Originalsprache)
In colorectal cancer (CRC), attempts to identify cancer cell-specific markers to guide antibody-mediated therapeutics have failed to uncover markers that are both exclusive to cancer tissues and abundant across CRCs. Alternatively, cancer-associated fibroblasts (CAFs), which are abundant in the tumor microenvironment and upregulate unique surface markers, are not found in healthy tissues. Here, we evaluated the expression patterns of CAF-associated proteins α-smooth muscle actin (αSMA), fibroblast activation protein (FAP), podoplanin (PDPN), matrix metalloproteinase-2 (MMP2), transgelin (TAGLN), and THY1. While αSMA and THY1 were abundant in cancer tissues, high abundance in normal tissues limited their targeting potential. FAP was present in 94.5% of primary and metastatic CRC tissues and absent in 93.7% of adjacent normal colon and liver tissues assessed. These results indicate that FAP is a promising target for antibody conjugates with potential for broad application in CRC. Co-expression analyses showed that CRCs simultaneously expressing high levels of PDPN, MMP2, and THY1 were enriched for immune-related signatures, indicating potential for antibody-mediated immune engagers. Overall, this work highlights the potential of CAF proteins to act as therapeutic targets for novel anticancer agents and become important therapeutic biomarkers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53726, USA.
- McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin, Madison, WI 53705, USA.
- Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA.
- Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
- Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53726, USA.
- Department of Radiology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706, USA.
ORCID-Profile: Cheri A Pasch, Wei Zhang
Förderung
- NCI NIH HHS
- V Foundation
- 2018 Prostate Cancer Foundation Challenge Award
- Prostate Cancer Foundation Young Investigator Award
- ACI/Schwenn Family Professorship
- JD Fluno Colorectal Cancer Precision Medicine Program
- NRSA
- NCI
Zitieren
APA
Shah, R., Johnson, K. A., Lippert, A. E. L., Kraus, S. G., Emmerich, P. B., Pasch, C. A., Zhang, W., Matkowskyj, K. A., LeBeau, A. M., & Deming, D. A. (2024). Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers. Cancers, 16(18), 3158. https://doi.org/10.3390/cancers16183158
Vancouver
Shah R, Johnson KA, Lippert AEL, Kraus SG, Emmerich PB, Pasch CA, et al. Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers. Cancers. 2024;16(18):3158. doi:10.3390/cancers16183158
BibTeX
@article{Shah2024,
author = {Shah, Ruchi and Johnson, Katherine A and Lippert, Anna E L and Kraus, Sean G and Emmerich, Philip B and Pasch, Cheri A and Zhang, Wei and Matkowskyj, Kristina A and LeBeau, Aaron M and Deming, Dustin A},
title = {Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal Cancers},
journal = {Cancers},
year = {2024},
volume = {16},
number = {18},
pages = {3158},
doi = {10.3390/cancers16183158}
}
EUVIMED